Table 1.
Detailed antimicrobial susceptibility testing results for strain S_KLB.
| Drug class | Drug | Concentration | Bacteriostatic ring diameter (mm) | Result | Standard f criterion |
|---|---|---|---|---|---|
| Beta-lactams | Imipenem | 10 μg | 9 | R | 23(S), 20-22(I), 19(R) |
| Oxacillin | 10 μg | 6 | R | 13(S), 11-12(I), 10(R) | |
| Macrolides | Azithromycin | 15 μg | 6 | R | 12(S), 11(I), 10(R) |
| Erythromycin | 15 μg | 6 | R | 23(S), 14-22(I), 13(R) | |
| Aminoglycosides | Gentamicin | 10 μg | 14 | I | 15(S), 13-14(I), 12(R) |
| Kanamycin | 30 μg | 15 | I | 18(S), 14-17(I), 13(R) | |
| Amikacin | 30 μg | 11 | R | 17(S), 15-16(I), 14(R) | |
| Cephalosporins | Cefotaxime | 30 μg | 18 | R | 26(S), 23-25(I), 22(R) |
| Cefoperazone | 75 μg | 18 | I | 21(S), 16-20(I), 15(R) | |
| Cefuroxime Axetil | 30 μg | 16 | I | 18(S), 15-17(I), 14(R) | |
| Quinolones | Enrofloxacin | 5 μg | 19 | S | 19(S), 14-18(I), 13(R) |
| Levofloxacin | 5 μg | 19 | I | 21(S), 17-20(I), 16(R) | |
| Fluoroquinolones | Ciprofloxacin | 10 μg | 14 | R | 26(S), 22-25(I), 21(R) |
| Aminocyclitols | Spectinomycin | 100 μg | 14 | R | 18(S), 15-17(I), 14(R) |
| Tetracyclines | Doxycycline | 30 μg | 15 | I | 18(S), 15-17(I), 14(R) |
| Glycopeptides | Teicoplanin | 30 μg | 6 | R | 14(S), 11-13(I), 10(R) |
| Nitrofurans | Fosfomycin | 200 μg | 20 | S | 16(S), 13-15(I), 12(R) |
| Monobactams | Aztreonam | 30 μg | 24 | S | 21(S), 18–20(I), 17(R) |
| Ansamycins | Rifampicin | 5 μg | 8 | R | 20(S), 17-19(I), 16(R) |
| Polypeptides | Polymyxin | 300 μg | 10 | R | ≥14 (S), <14 (R) |